Medicare Enrolled
Dr. Misty Poole, M.D.
Internal Medicine · Vidalia, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Poole from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Poole?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Poole
Dr. Misty Poole is an internal medicine specialist in Vidalia, GA, with 17 years of NPI registration. Based on federal Medicare data, Dr. Poole performed 3,933 Medicare services across 1,501 unique beneficiaries.
Between the years covered by Open Payments, Dr. Poole received a total of $3,400 from 46 pharmaceutical and/or device companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Poole is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 9% volume in GA
$3,400 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,933
Medicare services
Top 9% in GA for internal medicine
1,501
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~231 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,612 | $79 | $199 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
740 | $0 | $4 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
321 | $120 | $242 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
293 | $0 | $8 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
209 | $10 | $40 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
162 | $3 | $20 |
| Annual depression screening | 148 | $17 | $25 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
79 | $33 | $39 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
78 | $25 | $32 |
| Transitional care management, high complexity Coordination of care for a patient transitioning from a short-term hospital stay or other facility to home or another care setting. This service addresses a high-complexity medical problem. |
60 | $203 | $315 |
| Influenza virus detection test A laboratory test that uses an immunoassay technique to detect the presence of the influenza virus through direct visual observation. |
58 | $16 | $55 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
53 | $0 | $82 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $72 | $270 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
23 | $38 | $135 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $58 | $155 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
16 | $14 | $40 |
| Routine 12-lead ECG screening A standard 12-lead electrocardiogram performed as part of an initial preventive physical examination. The service includes both the performance of the test and the physician's interpretation and report. |
12 | $4 | $25 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
11 | $155 | $227 |
| Annual wellness visit, initial visit A yearly appointment to review your health and create a personalized prevention plan. This initial visit focuses on preventive care and health assessment. |
11 | $155 | $252 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$3,400
Total received (2018-2024)
Avg $486/year across 7 years
Top 22% in GA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
233
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,355 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$45 (1.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$677
2023
$685
2022
$347
2021
$392
2020
$171
2019
$475
2018
$651
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$134
PFIZER INC.
$96
Lilly USA, LLC
$75
AstraZeneca Pharmaceuticals LP
$62
Amgen Inc.
$62
ABBVIE INC.
$55
Boehringer Ingelheim Pharmaceuticals, Inc.
$50
Bayer Healthcare Pharmaceuticals Inc.
$39
Esperion Therapeutics, Inc.
$26
Phathom Pharmaceuticals, Inc.
$23
GlaxoSmithKline, LLC.
$19
IDORSIA PHARMACEUTICALS US INC
$19
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$17
Top 3 companies account for 45.2% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$1,101
AstraZeneca Pharmaceuticals LP
$257
Takeda Pharmaceuticals U.S.A., Inc.
$205
PFIZER INC.
$197
Amgen Inc.
$195
ABBVIE INC.
$167
Lilly USA, LLC
$158
SANOFI-AVENTIS U.S. LLC
$108
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
Bayer Healthcare Pharmaceuticals Inc.
$75
GlaxoSmithKline, LLC.
$71
Janssen Pharmaceuticals, Inc
$55
Merck Sharp & Dohme Corporation
$46
Medtronic Vascular, Inc.
$35
Axsome Therapeutics, Inc.
$34
Amneal Pharmaceuticals LLC
$32
Kowa Pharmaceuticals America, Inc.
$31
IDORSIA PHARMACEUTICALS US INC
$31
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$29
Sunovion Pharmaceuticals Inc.
$29
Eisai Inc.
$28
Esperion Therapeutics, Inc.
$26
Dexcom, Inc.
$23
Phathom Pharmaceuticals, Inc.
$23
Vanda Pharmaceuticals Inc.
$22
Biohaven Pharmaceutical Holding Company Ltd.
$20
Daiichi Sankyo Inc.
$20
Ascensia Diabetes Care US Inc.
$20
Azurity Pharmaceuticals, Inc.
$20
Sumitomo Pharma America, Inc.
$19
EISAI INC.
$18
Exact Sciences Corporation
$18
Amarin Pharma Inc.
$17
IBSA Pharma Inc.
$17
Bausch Health US, LLC
$17
Supernus Pharmaceuticals, Inc.
$17
Boston Scientific Corporation
$16
Orexigen Therapeutics, Inc.
$16
Xeris Pharmaceuticals, Inc.
$15
Hikma Pharmaceuticals USA
$15
E.R. Squibb & Sons, L.L.C.
$14
DEXCOM, INC.
$14
AbbVie Inc.
$14
Allergan Inc.
$13
Biogen, Inc.
$11
Abbott Laboratories
$11
Top 3 companies account for 46.0% of all-time payments
Associated products mentioned in payments ›
AIRSUPRA · ANORO · APLENZIN · Aimovig · Amitiza · Auvelity · BREZTRI · BYSTOLIC · CHANTIX · CONTRAVE · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EVENITY · Edarbi · FARXIGA · FreeStyle Libre · GEMTESA · GENERAL PAIN MANAGEMENT · GVOKE HYPOPEN · HawkOne · Hetlioz · INJECTAFER · JANUVIA · JARDIANCE · Kerendia · LYRICA · Livalo · MOUNJARO · MOVANTIK · Mitigare · NEXLETOL · NURTEC ODT · NovoLog · Otezla · Ozempic · PRADAXA · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RYBELSUS · Rybelsus · SEGLENTIS · SOLIQUA · SOLIQUA 100/33 · SPINRAZA · STIOLTO · SYMBICORT · SYNJARDY · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · Tirosint · Tresiba · Trintellix · UBRELVY · UNITHROID · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Victoza · Vyvanse · Wegovy · XARELTO · XIFAXAN · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Internal medicine physicians within 10 mi
10
Per 100K population
37.1
County median income
$54,130
Nearest hospital
MEMORIAL HEALTH MEADOWS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Poole is a clinical cardiology specialist, with above-average Medicare volume (top 9% in GA), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Poole experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Poole performed 1,612 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Poole receive payments from pharmaceutical companies?
Yes. Dr. Poole received a total of $3,400 from 46 companies across 233 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Poole's costs compare to other internal medicine physicians in Vidalia?
Dr. Poole's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Poole) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Vidalia
Browse internal medicine physicians in Vidalia ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in GA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in GA
Which GA internal medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology